Shalini Sharp

Shalini Sharp

DirectoratBeOne Medicines· In proxies 2024–2025

Shalini Sharp sits on 1 public board.

Experience

  1. BeOne MedicinesPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +113%
  2. 2020 – Present: Neurocrine Biosciences, Inc. 2021 – Present: Organon & Co. 2024 – Present: Septerna, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?